Compare NGNE & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | RCKY |
|---|---|---|
| Founded | 2003 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 318.6M |
| IPO Year | 2014 | 1996 |
| Metric | NGNE | RCKY |
|---|---|---|
| Price | $27.00 | $43.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $63.57 | $40.00 |
| AVG Volume (30 Days) | ★ 138.7K | 42.5K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | 0.93 | ★ 94.74 |
| EPS | N/A | ★ 2.96 |
| Revenue | N/A | ★ $270,408,000.00 |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | ★ N/A | $14.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.78 | $13.05 |
| 52 Week High | $37.27 | $48.70 |
| Indicator | NGNE | RCKY |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 60.56 |
| Support Level | $19.40 | $28.57 |
| Resistance Level | $29.05 | $44.83 |
| Average True Range (ATR) | 1.86 | 1.50 |
| MACD | 0.53 | 0.13 |
| Stochastic Oscillator | 78.73 | 78.01 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.